![Eric Falcand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Falcand
Chairman at
LYTIX BIOPHARMA
Profile
Eric Falcand is currently Chairman at Lytix Biopharma.
AS since 2025, Independent Director at NETRIS Pharma SAS since 2024, Independent Director at Cytea Bio since 2023, Vice President & Head-Business Development at Servier Laboratories, and General Manager at Servier JSC.
Former roles include Chief Executive Officer at Servier IP UK Ltd. and Neopharmed Gentili SpA, Independent Director at GeNeuro SA (Switzerland), Head-Sales Division at Synthélabo SA from 1991 to 1997, Head-Business Development & Licensing at Servier Monde SAS, and Global Head-Business Development at Servier Group.
Education includes an MBA from EM Lyon Business School, a doctorate from Ecole Nationale Vétérinaire de Nantes, and graduate studies at Institut de Pharmacie Industrielle de Lyon.
Eric Falcand active positions
| Companies | Position | Start |
|---|---|---|
| LYTIX BIOPHARMA | Chairman | 2025-04-28 |
Servier CJSC
 Servier CJSC Researches and develops of pharmaceutical factory | Corporate Officer/Principal | - |
Servier Laboratories
 Servier Laboratories Operates as a pharmaceutical company | Corporate Officer/Principal | - |
NETRIS Pharma SAS
 NETRIS Pharma SAS Develops targeted therapies for the treatment of cancer | Director/Board Member | 2024-11-30 |
Former positions of Eric Falcand
| Companies | Position | End |
|---|---|---|
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Sales & Marketing | 1996-12-31 |
Servier Group | Corporate Officer/Principal | - |
Neopharmed Gentili SpA
 Neopharmed Gentili SpA Operates as a pharmaceutical company | Chief Executive Officer | - |
Servier Monde SAS
 Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Servier IP UK Ltd.
 Servier IP UK Ltd. Wholesales pharmaceutical products | Chief Executive Officer | - |
Training of Eric Falcand
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Manufactures pharmaceuticals | Health Technology |
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Servier Monde SAS
Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ecole Nationale Vétérinaire de Nantes
 Ecole Nationale Vétérinaire de Nantes Functions as a College/University | |
Institut de Pharmacie Industrielle de Lyon
 Institut de Pharmacie Industrielle de Lyon Functions as a College/University | |
Neopharmed Gentili SpA
Neopharmed Gentili SpA Operates as a pharmaceutical company | |
Servier IP UK Ltd.
Servier IP UK Ltd. Wholesales pharmaceutical products | |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) Engages in the research and development of pharmaceutical products to treat neurological diseases | |
Servier Laboratories
Servier Laboratories Operates as a pharmaceutical company | |
Servier CJSC
Servier CJSC Researches and develops of pharmaceutical factory | |
NETRIS Pharma SAS
NETRIS Pharma SAS Develops targeted therapies for the treatment of cancer | |
Servier Group |
- Stock Market
- Insiders
- Eric Falcand
